The Prevalence of Dyslipidemia among Type 2 Diabetes Mellitus Patients in Al-khums Diabetic Center-Libya
Abstract
Background: An increase in the prevalence of diabetes mellitus has led to an increase in renal and cardiovascular complications. For this complication, dyslipidemia is a known risk factor.
Objective: This study aimed to identify the prevalence and patterns of dyslipidemia in people with type 2 diabetes mellitus (T2DM) and to estimate the influence of clinical and lifestyle factors on dyslipidemia.
Results: A high prevalence of dyslipidemia (61%) was found in people with T2DM. The most common lipid abnormality in our study was a low level of HDL-C followed by high TG and high LDL-C respectively. There was no statistical difference between males and females in lipid abnormalities. There was a significant association between poor diabetic control, BMI, smoking, and low physical activity with the occurrence of dyslipidemia.
Conclusion: These studies indicate that dyslipidemia is a common complication of T2DM, with a high prevalence among T2DM patients. Control of diabetes mellitus, screening, and management of dyslipidemia will reduce the micro and macrovascular complications in T2DM patients.
Keywords: diabetes mellitus, dyslipidemia. Lipid profile.
References
American Diabetes Association. Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl. 1):S15-S33. doi: 10.2337/dc21-S002
Bhattarai MD, Adhikari D, Khanal MK, Poudyal BK, Singh AK, Yadav NK. Dyslipidemia and associated factors among the type 2 diabetes mellitus patients of Nepal. Diabetes Metab Syndr. 2019;13(1):557-562. doi: 10.1016/j.dsx.2018.11.041
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., … Holman, R. R. (1998). Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ, 316(7134), 823–828. https://doi.org/10.1136/ bmj.316.7134.823
Zhao, J.-V., Lu, F., Sun, J.-S., Gao, F.-H., & Sun, X.-Y. (2014). Prevalence of dyslipidemia in patients with type 2 diabetes mellitus in China: A meta-analysis. Chinese Medical Journal, 127(20), 3807–3813.https://doi.org/10. 3760/cma.j.issn.0366-6999.20140190
Zhu, W., Meng, Y.-F., Wu, Y., Xu, M., Lu, J., & Zhang, L. (2018). The prevalence, risk factors, and clinical outcomes of dyslipidemia in patients with diabetes: A systematic review and meta-analysis. Endocrine, 62(2), 207–214. https://doi.org/10.1007/s12020-018-1524-0
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106 (25):3143-421
ADA. Glycemic targets: Standards of medical care in diabetes-2020. Diabetes Care. 2020;43 (Supplement 1):S66-76. Yaseen M, Muhammad S, Zahra A. Dyslipidemia pattern and impact of duration of type 2 diabetes mellitus and increasing age of insulin resistance, insulin levels and dyslipidemia. IAJPS. (2020) 7:227–33.
WHO Consultation on Obesity (1999: Geneva, Switzerland) & World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. World Health Organ Tech Rep Ser (2000) 894:i–xii, 1-253.
Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss. Arterioscler Thromb Vasc Biol (2006) 26(5): 968–76. doi: 10.1161/01.ATV. 0000216787. 85457.f3
Baranwal JK, Maskey R, Majhi S, et al. Association between level of HbA1c and lipid profile in T2DM patients attending diabetic OPD at BPKIHS. Health Renaiss. 2017;13:16–23.
Naeem M, Khattak RM, Ur Rehman M, et al. The role of glycated hemoglobin (HbA1c) and serum lipid profile measurements to detect cardiovascular diseases in type 2 diabetic patients. South East Asia J Pub Health. 2016;5:30–34.
Sarfraz M, Sajid S, Ashraf MA. Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population. Saudi J Biol Sci. (2016) 23:761–6. doi: 10.1016/j.sjbs.2016.03.001.
Yaseen M, Muhammad S, Zahra A. Dyslipidemia pattern and impact of duration of type 2 diabetes mellitus and increasing age of insulin resistance, insulin levels and dyslipidemia. IAJPS. (2020) 7:227–33.
Saboo B, Talaviya P, Gupta A, Nimbark D, Luhar S, Prajapati J. Lipid profile and its correlation with glycemic control in type 2 diabetes mellitus. J Assoc Physicians India. 2017;65(7):20-25. PMID: 28799302.
Lopes-Virella MF, Virella G. Clinical significance of the humoral immune response to modified LDL in diabetes. Front Endocrinol (Lausanne). 2012;3:76. doi: 10.3389/fendo. 2012.00076..
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Aboubaker Saleh Alasga، Hatem Ali Abushaala، Mohammed Farhat Othman، Naser Mohammed Irqayah
This work is licensed under a Creative Commons Attribution 4.0 International License.
